A Double-Blind Randomized, Placebo-Controlled, Dose Escalating Study to Assess The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of ADC3680B Administered Orally to Healthy Volunteers and to Investigate Food Effects on Pharmacokinetics After Single Oral Doses of ADC3680B.
Phase of Trial: Phase I
Latest Information Update: 01 Jan 2013
At a glance
- Drugs ADC 3680 (Primary)
- Indications Acute asthma; Chronic obstructive pulmonary disease
- Focus Adverse reactions
- 01 Feb 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 Feb 2011 Actual end date (February 2011) added as reported by ClinicalTrials.gov.
- 14 Aug 2010 New trial record